대퇴 동맥 폐쇄 디바이스 시장 규모 : 제품 유형별, 시술 유형별, 기술별, 유통 채널별, 최종 사용자별, 지역별 예측

Global Femoral Artery Closure Devices Market Analysis

According to Verified Market Research, the Global Femoral Artery Closure Devices Market size was valued at USD 19.4 Billion in 2025 and is projected to reach USD 28.5 Billion by 2033, growing at a CAGR of 5.5% from 2027 to 2033.

Global Femoral Artery Closure Devices Market Definition

Femoral artery closure devices are specialised medical devices used to achieve rapid hemostasis (bleeding control) at the puncture site of the femoral artery following catheter-based diagnostic or interventional procedures. These procedures, such as angiography, angioplasty, or cardiac catheterisation, commonly require vascular access through the femoral artery located in the groin. After completion of the procedure, the arterial puncture must be sealed properly to prevent bleeding complications, hematoma formation, or prolonged immobility. Traditionally, manual compression was used to close the access site, which required extended pressure application and bed rest. Femoral artery closure devices provide a more efficient alternative by mechanically or biologically sealing the arterial entry point, significantly reducing time to hemostasis and patient recovery time.

These devices generally function using one of three mechanisms: collagen-based plugs, suture-mediated systems, or clip-based technologies. Collagen plug systems deploy a biodegradable material that promotes clotting at the puncture site, while suture-mediated devices stitch the arterial opening closed internally. Clip-based devices apply a small metallic or polymer clip to seal the vessel wall. The use of femoral artery closure devices enhances patient comfort, enables early ambulation, and lowers hospital stay duration, making them particularly valuable in high-volume cardiovascular centres. They are widely used in cardiology, radiology, and vascular surgery settings. With the rising number of minimally invasive procedures and increasing preference for outpatient interventions, these devices play a critical role in improving procedural efficiency, safety outcomes, and overall healthcare cost management.

Global Femoral Artery Closure Devices Market Overview

The femoral artery closure devices market revolves around medical technologies designed to seal the femoral artery puncture site after catheter-based procedures such as angiography, angioplasty, and other interventional cardiovascular treatments. During these procedures, physicians access the vascular system through the femoral artery in the groin. Once the intervention is completed, achieving rapid and effective hemostasis is critical to prevent bleeding and vascular complications. Traditionally, manual compression was used, requiring prolonged pressure application and extended bed rest. However, femoral artery closure devices streamline this process by deploying mechanical or bio absorbable systems such as collagen plugs, suture-mediated closures, or clip-based mechanisms to seal the arterial entry point. The process significantly reduces time to hemostasis, enabling faster patient stabilization and improved workflow efficiency in catheterization laboratories. Growing volumes of minimally invasive cardiac and peripheral vascular procedures are directly fueling market demand.

The advantages of these devices extend beyond procedural convenience. They enhance patient comfort by reducing post-procedure immobility, minimize complications such as hematoma and bleeding, and allow earlier ambulation, which contributes to shorter hospital stays. This has a direct economic impact by lowering healthcare costs and increasing bed turnover rates in hospitals and cardiac centres. Clinically, improved vascular closure supports better recovery outcomes, particularly in elderly or high-risk patients who may be more susceptible to bleeding complications. The devices are widely used in cardiology departments, specialty vascular clinics, and ambulatory surgical centres where efficiency and safety are paramount. Technological advancements, including large-bore closure systems for structural heart procedures, are further expanding their use. Overall, femoral artery closure devices play a crucial role in modern interventional medicine by enhancing safety, improving patient satisfaction, and supporting the broader shift toward minimally invasive therapeutic approaches.

Global Femoral Artery Closure Devices Market: Segmentation Analysis

The Global Femoral Artery Closure Devices Market is segmented based on Product Type, Procedure Type, Technology, Distribution Channel, End User, and Region.

Global Femoral Artery Closure Devices Market, By Product Type

Collagen Plug-Based Devices

Suture-Based Closure Devices

Clip-Based Closure Devices

Sealant/Sponge-Based Devices

Based on the Product Type, the market is segmented into Collagen Plug-Based Devices, Suture-Based Closure Devices, Clip-Based Closure Devices, and Sealant/Sponge-Based Devices. Among these, Collagen Plug-Based Devices hold the largest market share due to their ease of use, faster time to hemostasis, and strong clinical acceptance. These devices deploy bio absorbable collagen material at the arterial puncture site, promoting natural clot formation while providing immediate mechanical sealing. Their relatively simple deployment technique compared to suture-mediated systems makes them widely preferred in high-volume catheterization laboratories. Additionally, collagen-based systems are associated with reduced procedure time and quicker patient ambulation, supporting improved workflow efficiency in hospitals and cardiac centres.

Global Femoral Artery Closure Devices Market, By Procedure Type

Coronary Interventions

Peripheral Vascular Procedures

Structural Heart Procedures

Based on the Procedure Type, the market is divided into Coronary Interventions, Peripheral Vascular Procedures, Structural Heart Procedures, and Others. Among these, Coronary Interventions hold the largest market share due to the high global prevalence of cardiovascular diseases and the growing number of procedures such as angioplasty and coronary stent placements. These procedures frequently require femoral artery access, especially in complex or high-risk cases, increasing the demand for reliable closure devices. The rising geriatric population, which is more susceptible to coronary artery disease, further supports segment growth. Additionally, improvements in interventional cardiology techniques and expanding catheterisation laboratory infrastructure in emerging economies are contributing to higher procedural volumes. Compared to other segments, coronary procedures are performed more frequently worldwide, resulting in greater utilisation of femoral artery closure devices to ensure rapid hemostasis, reduce complications, and enable early patient ambulation.

Global Femoral Artery Closure Devices Market, By Technology

Bio-absorbable Materials

Non-absorbable Devices

Suture-Assisted Systems

Sealant-based Systems

Based on the Technology, the market is divided into Bio-absorbable Materials, Non-absorbable Devices, Suture-Assisted Systems, and Sealant-based Systems. Among these, Bio-absorbable Materials hold the largest market share due to their ability to naturally dissolve in the body after achieving hemostasis, reducing long-term complications and eliminating the need for device removal. These devices typically use collagen or polymer-based plugs that promote rapid clot formation and vessel sealing, making them highly preferred in cardiovascular and interventional radiology procedures. The growing volume of minimally invasive catheter-based interventions, combined with increasing focus on patient comfort and faster recovery, further supports their adoption. Additionally, biodegradable technologies reduce infection risks and foreign body reactions compared to permanent implants. While suture-assisted and sealant-based systems also show steady demand due to precise closure and strong sealing properties, bio-absorbable materials remain dominant because of their safety profile, convenience, and widespread clinical acceptance.

Global Femoral Artery Closure Devices Market, By Distribution Channel

Direct Sales (B2B Contracts)

Distributors & Dealers

E-commerce & Online Medical Platforms

Based on the Distribution Channel, the market is divided into Direct Sales (B2B Contracts), Distributors & Dealers, and E-commerce & Online Medical Platforms. Direct sales hold the largest market share due to the highly specialised and regulated nature of femoral artery closure devices. These products are primarily sold directly to hospitals, cardiac centres, and large healthcare institutions through long-term procurement contracts and tender-based purchasing systems. Direct engagement allows manufacturers to provide product training, clinical support, after-sales service, and technical assistance, which are critical for vascular intervention devices. Additionally, bulk purchasing agreements help hospitals secure competitive pricing and ensure a consistent supply. While distributors play a significant role in expanding reach in emerging markets, and online platforms are gradually growing, high-value interventional devices are still predominantly procured through direct manufacturer-to-hospital relationships, making direct sales the leading distribution channel.

Global Femoral Artery Closure Devices Market, By End User

Hospitals & Cardiac Centers

Ambulatory Surgical Centers (ASCs)

Specialty Clinics

Diagnostic Centers

Based on the End User, the market is divided into Hospitals & Cardiac Centers, Ambulatory Surgical Centers (ASCs), Specialty Clinics, and Diagnostic Centers. Among these, Hospitals & Cardiac Centers hold the largest market share due to the high volume of complex cardiovascular and interventional procedures performed in these facilities. Femoral artery closure devices are extensively used after angioplasty, cardiac catheterization, and other minimally invasive vascular interventions, which are predominantly conducted in hospital settings equipped with advanced catheterization laboratories. The presence of skilled cardiologists, comprehensive emergency care infrastructure, and post-procedural monitoring capabilities further supports segment dominance. Additionally, hospitals manage a larger number of high-risk and elderly patients who require reliable vascular closure solutions to minimize complications and recovery time.

Global Femoral Artery Closure Devices Market, By Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Based on Region, the market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America holds the largest share due to the high prevalence of cardiovascular diseases, a well-established healthcare infrastructure, and strong adoption of minimally invasive procedures. The presence of leading medical device manufacturers and rapid technological advancements further strengthen regional growth. Additionally, favourable reimbursement policies and higher healthcare expenditure support the widespread use of femoral artery closure devices in hospitals and cardiac centres. The United States, in particular, drives market dominance due to its large volume of interventional cardiology procedures and early adoption of innovative vascular closure technologies. While Asia Pacific is experiencing rapid growth, North America continues to lead in revenue contribution and technological innovation.

Global Femoral Artery Closure Devices Market Competitive Landscape

The "Global Femoral Artery Closure Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Terumo Corporation, Cardinal Health, Medtronic plc, Boston Scientific Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems, TZ Medical Inc., and Vivasure Medical Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 MARKET DEFINITION
• 1.2 MARKET SEGMENTATION
• 1.3 RESEARCH TIMELINES
• 1.4 ASSUMPTIONS
• 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 DATA MINING
• 2.2 SECONDARY RESEARCH
• 2.3 PRIMARY RESEARCH
• 2.4 SUBJECT MATTER EXPERT ADVICE
• 2.5 QUALITY CHECK
• 2.6 FINAL REVIEW
• 2.7 DATA TRIANGULATION
• 2.8 BOTTOM-UP APPROACH
• 2.9 TOP-DOWN APPROACH
• 2.10 RESEARCH FLOW
• 2.11 DATA DISTRIBUTION CHANNEL S

3 EXECUTIVE SUMMARY

• 3.1 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETOVERVIEW
• 3.2 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETESTIMATES AND FORECAST (USD BILLION)
• 3.3 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETECOLOGY MAPPING
• 3.4 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM
• 3.5 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETABSOLUTE MARKET OPPORTUNITY
• 3.6 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETATTR ACTIVENESS ANALYSIS, BY REGION
• 3.7 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETATTR ACTIVENESS ANALYSIS, BY PRODUCT TYPE
• 3.8 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETATTR ACTIVENESS ANALYSIS, BY PROCEDURE TYPE
• 3.9 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETATTR ACTIVENESS ANALYSIS, BY TECHNOLOGY
• 3.10 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETATTR ACTIVENESS ANALYSIS, BY DISTRIBUTION CHANNEL
• 3.11 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETATTR ACTIVENESS ANALYSIS, BY END-USER
• 3.12 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETGEOGRAPHICAL ANALYSIS (CAGR %)
• 3.13 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKET, BY PRODUCT TYPE (USD BILLION)
• 3.14 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKET, BY PROCEDURE TYPE (USD BILLION)
• 3.15 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKET, BY TECHNOLOGY(USD BILLION)
• 3.16 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)
• 3.17 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKET, BY END-USER (USD BILLION)
• 3.18 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKET, BY GEOGRAPHY (USD BILLION)
• 3.19 FUTURE MARKET OPPORTUNITIES

4 MARKET OUTLOOK

• 4.1 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETEVOLUTION
• 4.2 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKETOUTLOOK
• 4.3 MARKET DRIVERS
• 4.4 MARKET RESTRAINTS
• 4.5 MARKET TRENDS
• 4.6 MARKET OPPORTUNITY
• 4.7 PORTER'S FIVE FORCES ANALYSIS
  • 4.7.1 THREAT OF NEW ENTRANTS
  • 4.7.2 BARGAINING POWER OF SUPPLIERS
  • 4.7.3 BARGAINING POWER OF BUYERS
  • 4.7.4 THREAT OF SUBSTITUTE PRODUCT TYPES
  • 4.7.5 COMPETITIVE RIVALRY OF EXISTING COMPETITORS
• 4.8 VALUE CHAIN ANALYSIS
• 4.9 PRICING ANALYSIS
• 4.10 MACROECONOMIC ANALYSIS

5 MARKET, BY PRODUCT TYPE

• 5.1 OVERVIEW
• 5.2 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY PRODUCT TYPE
• 5.3 COLLAGEN PLUG-BASED DEVICES
• 5.4 SUTURE-BASED CLOSURE DEVICES
• 5.5 CLIP-BASED CLOSURE DEVICES
• 5.6 SEALANT/SPONGE-BASED DEVICES

6 MARKET, BY PROCEDURE TYPE

• 6.1 OVERVIEW
• 6.2 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY PROCEDURE TYPE
• 6.3 CORONARY INTERVENTIONS
• 6.4 PERIPHERAL VASCULAR PROCEDURES
• 6.5 STRUCTURAL HEART PROCEDURES
• 6.6 OTHERS

7 MARKET, BY TECHNOLOGY

• 7.1 OVERVIEW
• 7.2 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY TECHNOLOGY
• 7.3 BIO-ABSORBABLE MATERIALS
• 7.4 NON-ABSORBABLE DEVICES
• 7.5 SUTURE-ASSISTED SYSTEMS
• 7.6 SEALANT-BASED SYSTEMS

8 MARKET, BY DISTRIBUTION CHANNEL

• 8.1 OVERVIEW
• 8.2 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY DISTRIBUTION CHANNEL
• 8.3 DIRECT SALES (B2B CONTRACTS)
• 8.4 DISTRIBUTORS & DEALERS
• 8.5 E-COMMERCE & ONLINE MEDICAL PLATFORMS

9 MARKET, BY END-USER

• 9.1 OVERVIEW
• 9.2 GLOBAL FEMORAL ARTERY CLOSURE DEVICES MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY END-USER
• 9.3 HOSPITALS & CARDIAC CENTERS
• 9.4 AMBULATORY SURGICAL CENTERS (ASCS)
• 9.5 SPECIALTY CLINICS
• 9.6 DIAGNOSTIC CENTERS

10 MARKET, BY GEOGRAPHY

• 10.1 OVERVIEW
• 10.2 NORTH AMERICA
  • 10.2.1 U.S.
  • 10.2.2 CANADA
  • 10.2.3 MEXICO
• 10.3 EUROPE
  • 10.3.1 GERMANY
  • 10.3.2 U.K.
  • 10.3.3 FRANCE
  • 10.3.4 ITALY
  • 10.3.5 SPAIN
  • 10.3.6 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 CHINA
  • 10.4.2 JAPAN
  • 10.4.3 INDIA
  • 10.4.4 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 BRAZIL
  • 10.5.2 ARGENTINA
  • 10.5.3 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST AND AFRICA
  • 10.6.1 UAE
  • 10.6.2 SAUDI ARABIA
  • 10.6.3 SOUTH AFRICA
  • 10.6.4 REST OF MIDDLE EAST AND AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY DEVELOPMENT STRATEGIES
• 11.3 COMPANY REGIONAL FOOTPRINT
• 11.4 ACE MATRIX
  • 11.4.1 ACTIVE
  • 11.4.2 CUTTING EDGE
  • 11.4.3 EMERGING
  • 11.4.4 INNOVATORS

12 COMPANY PROFILES

• 12.1 OVERVIEW
• 12.2 ABBOTT LABORATORIES
• 12.3 TERUMO CORPORATION
• 12.4 CARDINAL HEALTH
• 12.5 MEDTRONIC PLC
• 12.6 BOSTON SCIENTIFIC CORPORATION
• 12.7 TELEFLEX INCORPORATED
• 12.8 COOK MEDICAL
• 12.9 ERIT MEDICAL SYSTEMS
• 12.10 TZ MEDICAL INC
• 12.11 VIVASURE MEDICAL LTD